Category Specific RSS

Jennifer Chow

Chimeric Therapeutics granted US patent for its blood cancer technology

The United States Patent and Trademark Office (USPTO) has recently granted a patent to Australia-based clinical-stage cell therapy company Chimeric…

2 years ago

Chimeric’s cell therapy drug moves on to Phase 1B trial to treat malignant brain cancer

In 2020, the Department of Health and Aged Care revealed that approximately 2,000 Australians were diagnosed with brain cancer. New…

2 years ago